Annual Drug Patent Expiration for QINLOCK
Qinlock is a drug marketed by Deciphera Pharms and included in one NDA. It is available from a single supplier. There are ten patents protecting this drug.
This drug has sixty-six patent family members in thirteen countries.
The generic ingredient in QINLOCK is tripretinib. One registered supplier for this compound. Additional details are available on the ripretinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for Deciphera Pharms drug QINLOCK